Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

ANTIGEN SPECIFIC PLASMACYTOMAS AND ANTIBODIES DERIVED THEREFROM

  • Read more about ANTIGEN SPECIFIC PLASMACYTOMAS AND ANTIBODIES DERIVED THEREFROM
US Patent 5,705,150
Filed on 1993-07-13

TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES

  • Read more about TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES
US Application 08/132,708
Filed on 1993-10-06

POLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMA- CEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF TREATING...

  • Read more about POLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMA- CEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF TREATING...
US Patent 5,676,963
Filed on 1995-04-06

POLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMA- CEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF TREATING....

  • Read more about POLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMA- CEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF TREATING....
US Patent 5,718,892
Filed on 1995-04-06

SCREENING ASSAYS FOR COMPOUNDS THAT CAUSE APOPTOSIS AND RELATED COMPOUNDS

  • Read more about SCREENING ASSAYS FOR COMPOUNDS THAT CAUSE APOPTOSIS AND RELATED COMPOUNDS
US Patent 6,602,979
Filed on 1994-12-19

MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY

  • Read more about MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
US Patent 5,585,356
Filed on 1994-08-12

GENE THERAPY BY ADMINSTRATION OF GENETICALLY ENGINEERED CD34+ CELLS OBTAINED FROM CORD BLOOD

  • Read more about GENE THERAPY BY ADMINSTRATION OF GENETICALLY ENGINEERED CD34+ CELLS OBTAINED FROM CORD BLOOD
US Patent 6,984,379
Filed on 1994-04-08

SENSITIVE ASSAY METHOD FOR MEASURING CADMIUM LEVELS IN BIOLOGICAL MATERIALS

  • Read more about SENSITIVE ASSAY METHOD FOR MEASURING CADMIUM LEVELS IN BIOLOGICAL MATERIALS
US Application 08/399,616
Filed on 1995-03-07

MARKERS OF PROTEOLYTIC BLOOD BRAIN BARRIER DISRUPTION IN CEREBROSPINAL FLUID IN NEUROLOGICAL DISEASES

  • Read more about MARKERS OF PROTEOLYTIC BLOOD BRAIN BARRIER DISRUPTION IN CEREBROSPINAL FLUID IN NEUROLOGICAL DISEASES
US Application 08/522,720
Filed on 1995-09-01

NOVEL AROYLANILINE DERIVATIVES, COMPOSITIONS AND USES THEREOF

  • Read more about NOVEL AROYLANILINE DERIVATIVES, COMPOSITIONS AND USES THEREOF
US Patent 5,681,832
Filed on 1995-02-17

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1578
  • Page 1579
  • Page 1580
  • Page 1581
  • Page 1582
  • Page 1583
  • Page 1584
  • Page 1585
  • Page 1586
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health